ECRAID-PRIME

Belgium France Germany Ireland Poland Spain United Kingdom Georgia
|
2024
  • Adults (18-64 years)
  • Community
  • Primary care
  • SARS-CoV-2
  • Influenza virus
  • Influenza A(H5N1) virus
  • Acute COVID-19
  • Influenza
  • Avian Influenza
  • Pharmacological intervention
  • Nitric Oxide Nasal Spray